The Jetstream G3™ Calcium Study

Inclusion criteria

• The patient is ≥ 18 years of age.
• Patient has claudication determined to be due to femoropopliteal lesion(s) requiring revascularization.
• The target lesion(s) is/are located in the common femoral, superficial femoral or popliteal arteries.
• The reference vessel lumen (proximal to target lesion) is ≥ 3.0mm.
• The patient is an acceptable candidate for percutaneous intervention using the Jetstream G3 System in accordance with its labeled indications and instructions for use.
• The patient has signed approved informed consent.
• Moderate or severe vessel obstructive intraluminal calcification as demonstrated by IVUS and angiography.

Exclusion criteria

• Patient has an uncontrollable allergy to nitinol, stainless steel or other stent materials or to contrast agent.
• Patient is unable to take appropriate anti-platelet therapy.
• Patient has no distal runoff vessels.
• Deep wall calcium.
• Interventional treatment is intended for in-stent restenosis at the peripheral vascular site.
• Patient has target vessel with moderate or severe angulation (e.g., >30 degrees) or tortuosity at the treatment segment.
• Patient has a history of coagulopathy or hypercoagulable bleeding disorder.
• Patient is receiving hemodialysis or has impaired renal function (creatinine is > 2.5 mg/dl) at the time of treatment.
• Patient has evidence of intracranial or gastrointestinal bleeding within the past 3 months.
• Patient has had severe trauma, fracture, major surgery or biopsy of a parenchymal organ within the past 14 days.
• Patient is pregnant or nursing a child.
• Intended interventional treatment includes planned laser, brachytherapy or atherectomy procedure other than the Jetstream G3 System.

-